NCT04225052

Clinical Trial to Evaluate the Safety and Pharmacokinetics of YHP1903 in Healthy Volunteers

A Randomized, Open-label, Single Dose, Crossover Clinical Trial to Compare the Safety and Pharmacokinetics of YHP1903 in Healthy Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 34 (actual)
• Sponsor: Yuhan Corporation · Industry
• Sex: All
• Age: 19 Years – 55 Years
• Healthy volunteers: Accepted

Summary

A randomized, open-label, single dose, crossover clinical trial to evaluate the safety and pharmacokinetics of YHP1903 in healthy volunteers

Detailed description

32 healthy subjects wil be randomized one of 2 groups in the same ratio. Subjects in group 1 will be administered "comparator" and "YHP1903" by cross-over design on day1, 8. Subjects in group 2 will be administered "YHP1903" and "comparator" by cross-over design on day1, 8.

Conditions

• Healthy Volunteer

Interventions

Type	Name	Description
DRUG	YHP1903	YHP1903 Tab. 1mg
DRUG	Champix	Comparator Champix Tab. 1mg

Timeline

• Start date: 2019-12-19
• Primary completion: 2020-01-08
• Completion: 2020-01-14
• First posted: 2020-01-13
• Last updated: 2020-01-23

Locations

1 site across 1 country: South Korea